You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 10, October 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immunoglobulin and Complement Deposits in Nerves of Patients With Chronic Relapsing Polyneuropathy

Marinos C. Dalakas, MD; W. King Engel, MD

Arch Neurol. 1980;37(10):637-640.


Abstract

• Sural nerve biopsy specimens from seven patients with chronic relapsing polyneuropathy (CRP) were studied by direct immunofluorescence. Granular deposits containing IgM (7/7) and C3 (6/7) (and occasionally IgG, 3/7) were found in intraneural blood vessels. Linear deposits of IgM (6/7) (and occasionally IgG, 3/7) without C3 (0/7) were found on the Schwann cell plasmalemma (and sometimes extending deeper into the Schwann cell) of yet undemyelinated portions of nerve fibers. Albumin and fibrinogen were not found in any locus. In sural nerves of ten disease-control patients with nondysimmune chronic peripheral neuropathies, no deposits were seen on the vessels or the nerve fibers. The Schwann cell deposits may reflect a complement-independent IgM antibody toxic to Schwann cells that underlies the pathogenesis of CRP, perhaps facilitated in its passage across the blood-nerve barrier by damage from the complement-binding IgM complexes in the intraneural vessels.



Author Affiliations

From the Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Md.


Footnotes

Accepted for publication Nov 12, 1979.

Reprint requests to Clinical Center, Room 10-D-18, National Institutes of Health, Bethesda, MD 20205 (Dr Dalakas).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Pathogenesis and treatment of immune-mediated neuropathies
Lehmann et al.
Therapeutic Advances in Neurological Disorders 2009;2:261-281.
ABSTRACT  

Chronic Inflammatory Demyelinating Polyneuropathy
Koller et al.
NEJM 2005;352:1343-1356.
FULL TEXT  

Immune mechanisms in chronic inflammatory demyelinating neuropathy
Kieseier et al.
Neurology 2002;59:S7-12.
ABSTRACT | FULL TEXT  

Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies
Dalakas
Neurology 2002;59:S13-21.
ABSTRACT | FULL TEXT  

Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy
Nagamatsu et al.
J. Neurol. Neurosurg. Psychiatry 1999;66:727-733.
ABSTRACT | FULL TEXT  

Polymyositis Associated With AIDS Retrovirus
Dalakas et al.
JAMA 1986;256:2381-2383.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.